ARCH Venture Partners XII, LLC, 10% Owner at Neumora Therapeutics, Inc. (NMRA), bought 1,915,700 shares at $2.61 ($5.0M) on 2025-10-27, disclosed to the SEC on 2025-10-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| NMRA | BUY | 2023-11-07 | $1.9M | — | Filing → |